Hoffmann R, Dawson N F, Wade J D, Otvös L
Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
J Pept Res. 1997 Aug;50(2):132-42. doi: 10.1111/j.1399-3011.1997.tb01178.x.
The microtubule-associated protein tau of normal brains is attached to tubulin through its 18-amino-acid repeat units. In the paired helical filaments (PHF) of Alzheimer's disease, however, tau is oligomerized in an abnormally hyperphosphorylated from (PHF-tau). tau contains two cysteine residues in repeat units 2 and 3, but only the R3-R3 homodimer is present in PHF-tau. A serine residue two amino acids downstream of the R3 cysteine is a major phosphate acceptor site for protein kinase C. In the work repeated here, we used synthetic peptides corresponding to R2, R3 and phosphorylated R3 to determine the binding of the tau repeat peptides to a peptide fragment corresponding to the C-terminal domain of beta-tubulin and to study the kinetics of homo- and heterodimer formation. Additionally, we studied two major biochemical properties of the peptides that distinguish between normal tau and PHF-tau: conformation and metabolic stability. All R2 and R3 peptides bound specifically to the tubulin peptide regardless of the state of phosphorylation or dimerization. The reverse-turn conformation of the tau repeat peptides in the presence of the tubulin peptide remained unaffected. Phosphorylation slightly loosened the turn structure of the monomeric and dimeric peptides, and did not univocally affect the serum stability of the peptides or the ability of the peptides to form dimers. The isolated R2 and R3 units formed homodimers approximately in the same rate. When the two peptides were mixed, however, the R2-R3 heterodimer was formed preferentially over the homodimers. The dimers were generally more stable in human serum than the monomers. Our results with the synthetic peptide fragments of tau indicate that neither oxidation nor phosphorylation of the repeat units is able to generate extended structure such as that found in PHF-tau. Additionally, phosphorylation of Ser324 does not appear to modulate the kinetics of oligomerization of tau, and in general biochemistry terms, does not affect disulfide bridge formation nearby. In agreement with studies at the full-protein level, the formation of homodimers of the peptides, a model of the self-association of tau, is not preferred. If the dimers are formed, however, their clearance is considerably slower than that of the monomers, explaining the remarkable protease resistance of PHF-tau in the affected brains.
正常大脑中的微管相关蛋白tau通过其18个氨基酸的重复单元与微管蛋白相连。然而,在阿尔茨海默病的成对螺旋丝(PHF)中,tau以异常高度磷酸化的形式(PHF-tau)寡聚化。tau在重复单元2和3中含有两个半胱氨酸残基,但在PHF-tau中仅存在R3-R3同型二聚体。R3半胱氨酸下游两个氨基酸处的丝氨酸残基是蛋白激酶C的主要磷酸化位点。在本文重复的研究中,我们使用了与R2、R3和磷酸化R3对应的合成肽,以确定tau重复肽与对应于β-微管蛋白C末端结构域的肽片段的结合,并研究同型和异型二聚体形成的动力学。此外,我们研究了区分正常tau和PHF-tau的肽的两个主要生化特性:构象和代谢稳定性。所有R2和R3肽都特异性地结合到微管蛋白肽上,而与磷酸化或二聚化状态无关。在微管蛋白肽存在的情况下,tau重复肽的反向转折构象不受影响。磷酸化略微松弛了单体和二聚体肽的转折结构,并且对肽的血清稳定性或肽形成二聚体的能力没有明确的影响。分离的R2和R3单元以大致相同的速率形成同型二聚体。然而,当将这两种肽混合时,优先形成R2-R3异型二聚体而非同型二聚体。二聚体在人血清中通常比单体更稳定。我们对tau合成肽片段的研究结果表明,重复单元的氧化和磷酸化都不能产生如PHF-tau中发现的伸展结构。此外,Ser324的磷酸化似乎不会调节tau寡聚化的动力学,并且一般从生物化学角度来看,不会影响附近二硫键桥的形成。与全蛋白水平的研究一致,肽的同型二聚体的形成(tau自组装的模型)并非首选。然而,如果形成二聚体,它们的清除速度比单体慢得多,这解释了受影响大脑中PHF-tau显著的蛋白酶抗性。